Cargando…
Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca)
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Neurología. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173493/ http://dx.doi.org/10.1016/j.nrl.2021.05.007 |
| _version_ | 1783702733567557632 |
|---|---|
| author | Crespo Burillo, J.A. Loriente Martínez, C. García Arguedas, C. Mora Pueyo, F.J. |
| author_facet | Crespo Burillo, J.A. Loriente Martínez, C. García Arguedas, C. Mora Pueyo, F.J. |
| author_sort | Crespo Burillo, J.A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8173493 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Sociedad Española de Neurología. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81734932021-06-03 Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) Crespo Burillo, J.A. Loriente Martínez, C. García Arguedas, C. Mora Pueyo, F.J. Neurologia Carta Al Editor Sociedad Española de Neurología. Published by Elsevier España, S.L.U. 2021-09 2021-06-03 /pmc/articles/PMC8173493/ http://dx.doi.org/10.1016/j.nrl.2021.05.007 Text en © 2021 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta Al Editor Crespo Burillo, J.A. Loriente Martínez, C. García Arguedas, C. Mora Pueyo, F.J. Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) |
| title | Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) |
| title_full | Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) |
| title_fullStr | Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) |
| title_full_unstemmed | Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) |
| title_short | Neuralgia amiotrófica secundaria a vacuna contra COVID-19 Vaxzevria (AstraZeneca) |
| title_sort | neuralgia amiotrófica secundaria a vacuna contra covid-19 vaxzevria (astrazeneca) |
| topic | Carta Al Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173493/ http://dx.doi.org/10.1016/j.nrl.2021.05.007 |
| work_keys_str_mv | AT crespoburilloja neuralgiaamiotroficasecundariaavacunacontracovid19vaxzevriaastrazeneca AT lorientemartinezc neuralgiaamiotroficasecundariaavacunacontracovid19vaxzevriaastrazeneca AT garciaarguedasc neuralgiaamiotroficasecundariaavacunacontracovid19vaxzevriaastrazeneca AT morapueyofj neuralgiaamiotroficasecundariaavacunacontracovid19vaxzevriaastrazeneca |